Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report MCL-1 overexpression drives venetoclax resistance in AML, DLBCL, and myeloma. Explore direct inhibitors, CDK9 suppression, NOXA induction, and combination strategies.
Article | Report Mapping the 2026 quantum dot solar concentrator patent and literature landscape: LSC efficiencies, QDSSC records, geographic IP hotspots, and emerging eco-design strategies.
Article | Report How to improve oxidation stability of sulfide solid electrolytes at the cathode interface without sacrificing ionic conductivity — strategies from 20+ patents and studies.
Article | Report Explore the 2026 electrochemical methane activation landscape: key catalyst clusters, SOEC selectivity data, ambient-condition breakthroughs, and strategic IP implications.
Article | Report How aryl-sulfonamide molecular glues degrade RBM39 via CRL4-DCAF15, driving activity in leukemia, neuroblastoma, and ovarian cancer. Pipeline and IP signals.
Article | Report How single-ion conducting polymer electrolytes push lithium transference numbers toward unity, eliminate concentration polarization, and suppress dendrite growth in lithium metal batteries.
Article | Report A deep-dive into thermoelectric module packaging innovation: hermetic encapsulation, flexible substrates, IC spot-cooling, and the assignees shaping the 2026 landscape.
Article | Report How cryo-EM reveals atomic-scale SEI nanostructure in lithium-metal, lithium-ion, and sodium batteries — key findings, workflows, and research trends.
Article | Report How NPC and NSC therapies are advancing stroke recovery, spinal cord injury, and neurodegeneration — from iPSC-derived cells to Phase II trials.
Article | Report Explore the 2026 thermoelectric module packaging landscape: hermetic encapsulation, flexible substrates, IC spot-cooling, and key patent assignees from Kyocera to Google.
Article | Report How cryo-EM reveals atomic-scale SEI nanostructure in next-generation batteries — key findings on Li₂CO₃ stability, 3D conformality, and sodium systems.
Article | Report How LNP-delivered mRNA and engineered viral vectors are reshaping CAR-T therapy by programming T cells directly inside the body — bypassing costly ex vivo manufacturing.
Article | Report Microrobotic drug delivery is approaching clinical translation. Explore propulsion mechanisms, application domains, geographic leaders, and emerging IP opportunities in this 2026 landscape.
Article | Report How do hot carrier injection and bias temperature instability differ as dominant aging mechanisms at 3nm? Physics, scaling behavior, and coupled interactions explained.
Article | Report Explore the dendritic cell vaccine therapy pipeline in solid tumors: personalized antigen loading, mRNA electroporation, DC-tumor fusion, and checkpoint combination strategies.